BioCentury
ARTICLE | Company News

Inflazyme to acquire GlycoDesign

April 9, 2003 7:00 AM UTC

Inflazyme (TSE:IZP) will acquire glycobiology company GlycoDesign (TSE:GD) in a stock deal worth about C$12.8 million (US$8.7 million) based on a 10-day average stock price for IZP of C$0.58. IZP will...